Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

CORDRAN N

FLURANDRENOLIDE; NEOMYCIN SULFATE

Standard Dose
0.05%;EQ 3.5MG BASE/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CORDRAN N is listed in Drugs@FDA under application 050346 (NDA).

Marketing status: Discontinued Active ingredient FLURANDRENOLIDE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.05%;EQ 3.5MG BASE/GM Sponsor LILLY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CORDRAN N is listed in Drugs@FDA under application 050346 (NDA). Marketing status: Discontinued Active ingredient FLURANDRENOLIDE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.05%;EQ 3.5MG BASE/GM Sponsor LILLY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
CORDRAN N (FLURANDRENOLIDE; NEOMYCIN SULFATE) | Drug Monograph | MedicHelpline